Sichenzia Ross Ference Kesner LLP Represents AYTU Bioscience, Inc., in $12 Million Public Offering
Press Release – New York, NY – March 6, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented AYTU Bioscience, Inc. (NASDAQ: AYTU) in a $12 million public offering of Class A Units, comprising common stock and warrants and Class B Units comprising Series B Preferred Stock and Warrants. A total of 19,520,000 Class A Units were sold at a price of $0.45 per unit and 3,216 Class B Units were sold at a price of $1,000 per unit. The warrants are exercisable at a price of $0.54 per share for a term of 5 years. Joseph Gunnar & Co. acted as the Sole Book Running Managing Underwriter and Fordham Financial Management, Inc. acted as the Lead Managing Underwriter.
AYTU is a specialty Life Sciences Company focused on global commercialization of novel products in the field of urology. The Sichenzia Ross Ference Kesner LLP team was led by Partners, Gregory Sichenzia and Marcelle Balcombe and Counsel, Jeff Cahlon.
Visit SRFK's LinkedIn page
Latest posts by Sichenzia Ross Ference Kesner LLP (see all)
- Founding Partner Marc Ross Speaks at Benzinga Cannabis Capital Conference - August 15, 2018
- Founding Partner Gregory Sichenzia Featured in the Media Discussing Scrutiny of Elon Musk’s Twitter Communications - August 15, 2018
- Founding Partner Gregory Sichenzia Featured on Business Insider Discussing Elon Musk’s Tweets and Securities Legality - August 8, 2018